|
English
|
正體中文
|
简体中文
|
總筆數 :2856408
|
|
造訪人次 :
53365135
線上人數 :
1188
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 258356-258365 / 2348971 (共234898頁)
<< < 25831 25832 25833 25834 25835 25836 25837 25838 25839 25840 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2015 |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang, James C-H; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long; 楊志新; 余忠仁 |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
CHIH-HSIN YANG; Sequist L.V; Geater S.L; Tsai C.-M; Mok T.S.K; Schuler M; Yamamoto N; Yu C.-J; Ou S.H.I; Zhou C; Massey D; Zazulina V; Wu Y.-L.; Wu Y.-L.;Zazulina V;Massey D;Zhou C;Ou S.H.I;Yu C.-J;Yamamoto N;Schuler M;Mok T.S.K;Tsai C.-M;Geater S.L;Sequist L.V;Chih-Hsin Yang |
| 臺大學術典藏 |
2022-06-27T07:01:36Z |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang J.C.-H.; Sequist L.V.; Geater S.L.; Tsai C.-M.; Mok T.S.K.; Schuler M.; Yamamoto N.; CHONG-JEN YU; Ou S.H.I.; Zhou C.; Massey D.; Zazulina V.; Wu Y.-L. |
| 臺大學術典藏 |
2020-05-26T09:26:26Z |
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations
|
Nakagawa K.;Fukuoka M;Morita S;Shimazaki M;Kaneko Y;Akazawa R;Takeda K;Nakagawa T;Kang J.-H;Takeda K;Inoue A;Kiura K;Kim S.-W;Nishio M;Chih-Hsin Yang;Tsai C.-M;Azuma K;Park K;Seto T;Hayashi H;Nokihara H;Murakami H; Murakami H; Nokihara H; Hayashi H; Seto T; Park K; Azuma K; Tsai C.-M; CHIH-HSIN YANG; Nishio M; Kim S.-W; Kiura K; Inoue A; Takeda K; Kang J.-H; Nakagawa T; Takeda K; Akazawa R; Kaneko Y; Shimazaki M; Morita S; Fukuoka M; Nakagawa K. |
| 臺大學術典藏 |
2014 |
Clinical activity of metronomic chemotherapy in liver cancers
|
Hsu C.-H.; Cheng A.-L.; Yu-Yun Shao;Cheng A.-L.;Hsu C.-H.; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
Clinical activity of metronomic chemotherapy in liver cancers
|
Shao Y.-Y.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2021-08-31T06:42:23Z |
Clinical activity of metronomic chemotherapy in liver cancers
|
Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H. |
| 嘉南藥理大學 |
2009 |
Clinical Acupuncture and Oriental Medicine
|
Elsevier SDOL |
| 臺大學術典藏 |
2021-07-08T01:20:51Z |
Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: A Meta-Analysis Involving 10 Randomized Clinical Trials and 71 553 Individuals
|
Lin, Donna Shu-Han; Lee, Jen-Kuang; WEN-JONE CHEN |
| 臺大學術典藏 |
2022-03-07T07:05:24Z |
Clinical Adverse Events Associated with Sodium-Glucose Cotransporter 2 Inhibitors: A Meta-Analysis Involving 10 Randomized Clinical Trials and 71 553 Individuals
|
Lin D.S.-H.; JEN-KUANG LEE; Chen W.-J. |
顯示項目 258356-258365 / 2348971 (共234898頁)
<< < 25831 25832 25833 25834 25835 25836 25837 25838 25839 25840 > >>
每頁顯示[10|25|50]項目
|
